Corey McCann - 03 Dec 2021 Form 4 Insider Report for Pear Therapeutics, Inc.

Transactions Table

Type	Sym	Class	Transaction	Shares	Shares After	Date	Ownership	Footnotes
transaction	PEARQ	Class A Common Stock	Award	+8,157,656	8,157,656	03 Dec 2021	Direct	F1
transaction	PEARQ	Class A Common Stock	Award	+1,685,913	1,685,913	03 Dec 2021	by The Corey M. McCann Irrevocable Trust of 2021	F2, F4, F5
transaction	PEARQ	Class A Common Stock	Award	+986,517	986,517	03 Dec 2021	by The McCann Family Trust	F3, F4, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for 5,540,268 shares of common stock of Private Pear previously held by Dr. McCann.
F2	Received in accordance with the terms of the Business Combination Agreement in exchange for 1,145,000 shares of common stock of Private Pear previously held by The Corey M. McCann Irrevocable Trust of 2021.
F3	Received in accordance with the terms of the Business Combination Agreement in exchange for 670,000 shares of common stock of Private Pear previously held by The McCann Family Trust.
F4	The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with respect to these shares, except to the extent of his pecuniary interest therein.
F5	Shares held in The Corey M. McCann Irrevocable Trust of 2021. The trustee of The Corey M. McCann Irrevocable Trust of 2021 is Mia E. Moll.
F6	Shares held in The McCann Family Trust. The trustee of The McCann Family Trust is Concord Trust Company.